Mr. Kurosaki is the Chief Financial Officer at Synchronicity Pharma. Previously, he was the Vice President, Finance & Administration at MacuSight, a developer for the treatment of serious ocular diseases. While at MacuSight, Mr. Kurosaki managed the financial and general operational aspects of the Company and played a key financial role in a license collaboration agreement with a publicly traded ophthalmology company. Prior to MacuSight, Mr. Kurosaki served as Director of Finance at Oculex Pharmaceuticals, which was acquired by Allergan in 2003 and ultimately marketed Ozurdex®, a biodegradable implant that has received regulatory approval in the US and abroad. Mr. Kurosaki also served as an audit manager at PricewaterhouseCoopers and is an active Certified Public Accountant in California. Mr. Kurosaki received his B.S. in Business Administration from the University of California at Berkeley.